Skip to content

Evaluation of Anxiety Reduction in the Cathlab by Means of Pharmacological and Non-pharmacological Strategies

Evaluation of Anxiety Reduction in the Cathlab by Means of Pharmacological and Non-pharmacological Strategies: EASY-HD Pilot Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07681180
Acronym
EASY-HD
Enrollment
60
Registered
2026-07-02
Start date
2026-08-01
Completion date
2027-03-01
Last updated
2026-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Care, Cardiovascular Disease, Pain and Anxiety During Cardiac Catheterization

Brief summary

The goal of this prospective pilot study is to learn if the use of virtual reality and/or relaxing soundscapes can help lower anxiety in adult patients undergoing a scheduled coronary angiography or angioplasty as compared to the standard of care. The main questions it aims to answer are: * The use of non-pharmacological strategies reduces intraprocedural stress and anxiety compared to standard of care * Reducing anxiety limits the use of pharmacological agents, which increases patient safety. Researchers will compare the use of relaxing soundscapes or virtual reality to the standard of care to see the effects of these strategies on pain, anxiety and stress. Participants will: * listen to relaxing soundscapes, OR experience virtual reality including soundscapes OR standard of care during their procedure, * Answer pain, anxiety and recovery questionnaires, * Answer satisfaction questionnaires.

Detailed description

The EASY-HD project is a prospective, randomized, controlled pilot study to evaluate the effectiveness of immersive nonpharmacological strategies, soundscapes, and virtual reality (VR) on the reduction of intraprocedural anxiety and stress in patients undergoing a scheduled hemodynamic intervention (coronary angiography and/or angioplasty). Adult patients will be included and randomized into three parallel groups (1:1:1): standard of care alone (control group), standard of care combined with relaxing soundscapes via headphones, or standard of care combined with virtual reality immersion in a soothing environment including sound. The devices will be set up 5 to 10 minutes before the procedure and continued througout. This minimal-risk study aims to determine the feasibility and potential clinical benefit of these simple, reproducible non-pharmacological approaches to improve patient comfort and possibly reduce the need for hemodynamic sedation.

Interventions

OTHERAuditive experience

Auditive distraction therapy

OTHERAudiovisual immersive experience

Virtual reality-lead audiovisual experience

Sponsors

Olivier F. Bertrand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults, 18 years or older * Scheduled hemodynamic intervention (coronary angiography and/or angioplasty) * Patient willing and able to understand the study * Signed informed consent

Exclusion criteria

* Scheduled complex procedure (CTO, structural) * Severe cognitive or psychiatric disorders * Major hearing/visual impairment * Severe motion sickness or history of malaise with Virtual Reality (VR) * Complaints of nausea or vomiting * History of epilepsy * Claustrophobia * Facial injuries * In clinical isolation (infection control)

Design outcomes

Primary

MeasureTime frameDescription
Change in patient-reported anxietyBaseline (preprocedural), periprocedural and at one-week follow-upChange from baseline in patient reported anxiety evaluated by anxiety questionnaires Visual Analog Score for anxiety (0 = Not anxious at all - 10 = Extremely anxious)
Change in patient-reported painBaseline, periprocedural and at one-week follow-upChange from baseline in patient reported pain evaluated by pain questionnaires Visual Analog Scale for pain (0=No pain - 10 = Worst pain possible)

Secondary

MeasureTime frameDescription
Use of analgesic and anxiolytic medicationsWithin 48 hours before and after the procedureUse vs no-use of analgesic (opioid/non-opioid) and/or anxiolytic medication. If analgesic and/or anxiolytic medication is used, its type, dose and frequency will be registered.
Change from baseline in physiological factors associated with pain and anxiety - Heart RateBaseline, periproceduralHeart rate (beats per minute)
Change from baseline in physiological factors associated with pain and anxiety - Respiratory RateBaseline, periproceduralRespiratory rate (breaths per minute)
Change from baseline in physiological factors associated with pain and anxiety - Blood PressureBaseline, PeriproceduralBlood pressure (mmHg)
Incidence of adverse events of interestWithin 10 days of the procedurePatient-reported nausea, dizziness and increased anxiety will be collected

Countries

Canada

Contacts

CONTACTMichele Jadin
michele.jadin@criucpq.ulaval.ca4186568711

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 3, 2026